BiotechKraft develops enzymatic processes that recover high-purity pharmaceutical and nutraceutical ingredients from the by-products of Norwegian fisheries and aquaculture.
Sequential hydrolysis protocols fractionate marine biomass into discrete molecular streams without harsh solvents or aggressive chemistry. Each stream is recovered at pharmaceutical-grade specification.
Inputs are by-products of established Norwegian fisheries and aquaculture: material that today is rendered, exported as low-value protein, or discarded. Our process treats them as source material for regulated APIs.
The cascade is engineered for maximal mass utilisation. Residual fractions are characterised for nutraceutical and feed applications, closing the loop between pharma-grade output and sustainable feedstock economics.
BiotechKraft's process platform is grounded in published research on the enzymatic systems that govern carbon cycling in marine and terrestrial biomass. The forthcoming publication situates lytic polysaccharide monooxygenases (LPMOs) at the intersection of climate science and industrial biorefinery design — the same enzymatic principles that underpin our ingredient recovery work.
Life sciences PhD (Sorbonne Université) with more than two decades in industrial and academic R&D. Corresponding author on the company's peer-reviewed scientific output. Leads scientific direction, IP strategy, and external partnerships.
Twenty years of corporate experience across Norway and Germany. Oversees financial planning, grant management, and corporate administration. Co-founder.
BiotechKraft is supported by senior Norwegian researchers and industry practitioners with direct, hands-on experience in marine bioprocess development. Engagements are formalised under written advisory agreements.
Norwegian academic researcher with more than thirty years of experience in marine biochemistry and the historical development of extraction processes from fisheries by-products. Advises on process design, scale-up considerations, and supplier networks for the biorefinery platform.